Severe COVID-19 has been linked with a cytokine storm38 and some cytokines are now the targets of COVID-19 therapies, i.e., IL-6 for which a monoclonal antibody therapy is being investigated for the treatment of critically ill COVID-19 patients39. The gene discussed is IL6; the disease is COVID-19.